A detailed history of Citigroup Inc transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 125 shares of ASRT stock, worth $152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125
Previous 17,079 99.27%
Holding current value
$152
Previous $16,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.75 - $1.31 $12,715 - $22,209
-16,954 Reduced 99.27%
125 $0
Q1 2024

May 10, 2024

SELL
$0.79 - $1.14 $10,294 - $14,855
-13,031 Reduced 43.28%
17,079 $16,000
Q4 2023

Feb 09, 2024

BUY
$1.02 - $2.57 $20,513 - $51,685
20,111 Added 201.13%
30,110 $32,000
Q3 2023

Nov 09, 2023

SELL
$2.52 - $5.69 $16,344 - $36,905
-6,486 Reduced 39.34%
9,999 $25,000
Q2 2023

Aug 10, 2023

BUY
$5.0 - $7.66 $80,130 - $122,759
16,026 Added 3491.5%
16,485 $89,000
Q1 2023

May 11, 2023

BUY
$3.54 - $6.66 $17 - $33
5 Added 1.1%
459 $2,000
Q4 2022

Feb 09, 2023

BUY
$2.11 - $4.3 $957 - $1,952
454 New
454 $1,000
Q2 2022

Aug 10, 2022

BUY
$1.88 - $3.42 $114 - $208
61 Added 244.0%
86 $0
Q1 2022

May 12, 2022

BUY
$2.06 - $3.0 $51 - $75
25 New
25 $0

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $58.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.